ALXO short interest
ALX Oncology Holdings Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 5,673,137 |
|---|---|
| Change vs prior report | -600,515 (-9.6%) |
| Change over six months | +155.2% |
| Days to cover | 3.79 (sector: 3.78) |
| Average daily volume | 1,495,736 |
| Rank in Healthcare | #555 of 922 by days to cover |
ALXO short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 5,673,137 | -9.6% | 3.79 | 1,495,736 |
| 2026-09-15 | 6,273,652 | -11.2% | 7.79 | 805,352 |
| 2026-08-31 | 7,064,802 | -7.2% | 12.28 | 575,105 |
| 2026-08-14 | 7,612,189 | -1.4% | 4.84 | 1,571,588 |
| 2026-07-31 | 7,718,258 | +3.5% | 13.28 | 581,146 |
| 2026-07-15 | 7,460,211 | +18.1% | 6.59 | 1,131,789 |
| 2026-06-30 | 6,318,290 | +144.0% | 2.06 | 3,060,345 |
| 2026-06-15 | 2,589,032 | +51.8% | 2.64 | 980,863 |
| 2026-05-29 | 1,705,895 | +23.6% | 1.33 | 1,283,230 |
| 2026-05-15 | 1,380,136 | -37.5% | 1.93 | 713,775 |
| 2026-04-30 | 2,206,868 | +7.9% | 1.87 | 1,183,029 |
| 2026-04-15 | 2,045,874 | -8.0% | 1.72 | 1,192,708 |
| 2026-03-31 | 2,222,798 | +81.7% | 2.89 | 768,037 |
| 2026-03-13 | 1,223,050 | +4.3% | 2.38 | 513,111 |
| 2026-02-27 | 1,172,124 | -0.2% | 1.21 | 968,784 |
| 2026-02-13 | 1,174,673 | +3.5% | 1.08 | 1,088,382 |
| 2026-01-30 | 1,135,216 | +4.5% | 2.75 | 413,360 |
| 2026-01-15 | 1,086,386 | +10.3% | 3.97 | 273,938 |
| 2025-12-31 | 985,188 | -6.0% | 6.74 | 146,258 |
| 2025-12-15 | 1,047,613 | +32.0% | 4.92 | 212,826 |
| 2025-11-28 | 793,867 | -55.4% | 3.36 | 236,484 |
| 2025-11-14 | 1,780,683 | -3.5% | 3.91 | 455,947 |
| 2025-10-31 | 1,844,412 | -0.9% | 5.41 | 341,167 |
| 2025-10-15 | 1,860,704 | +38.8% | 2.96 | 628,235 |
| 2025-09-30 | 1,340,930 | -15.0% | 1.42 | 941,728 |
import finzdata as yf
yf.Ticker("ALXO").short_interest # every report since 2017
yf.Client().short_interest(["ALXO"], start="2018-01-01")Healthcare short interest · ALXO price history · Who owns ALXO · All short interest